SCHEMBL22609192

SCHEMBL22609192

CCCCC1(O)OC(=O)c2c(I)cc(OC)cc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.56
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
POLK Q9UBT6 1/20 0.35
ELANE P08246 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP3A4 P08684 1/20 0.32
POLA1 P09884 2/20 0.32
GPR84 Q9NQS5 1/20 0.32
PTGS2 P35354 1/20 0.31
MYLK Q15746 1/20 0.31
CBX7 O95931 1/20 0.30
CDYL2 Q8N8U2 1/20 0.30
CDYL Q9Y232 1/20 0.30
CDY1; CDY1B Q9Y6F8 1/20 0.30
MEN1 O00255 1/20 0.30
GAA P10253 1/20 0.30
KMT2A Q03164 1/20 0.30
ESR1 P03372 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22609174 0.77 PTPN1 (0.48) PTPN1KDM4EALDH1A1MEN1GAA
SCHEMBL15294485 0.70 PTPN1 (1.00) PTPN1TDP1L3MBTL1ELANEKDM4E
SCHEMBL22609171 0.68 PTPN1 (0.70) PTPN1TDP1L3MBTL1
SCHEMBL22609169 0.68 PTPN1 (0.60) PTPN1TDP1L3MBTL1KDM4EALDH1A1
SCHEMBL21325292 0.65 NPSR1 (0.49) PTPN1TDP1L3MBTL1KDM4EALDH1A1
SCHEMBL23747991 0.64 CES2 (0.43) TDP1L3MBTL1
SCHEMBL31094210 0.63 SLC5A1 (0.37) PTPN1CYP3A4
SCHEMBL23747878 0.62 CYP2C9 (0.40) TDP1L3MBTL1CYP3A4MEN1GAA
SCHEMBL21547797 0.61 ALDH1A1 (0.44) PTPN1POLKKDM4EALDH1A1CYP3A4
SCHEMBL4028258 0.61 NPSR1 (0.49) TDP1L3MBTL1ALDH1A1CYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111819170-B Methods for synthesizing pulmonary clothing acids and analogs thereof 韩国海洋研究院 2023-12-29 CN disclosed
EP-3733656-B1 METHOD FOR SYNTHESIS OF LOBARIC ACID AND ANALOG THEREOF KOREA INSTITUTE OF OCEAN SCIENCE AND TECH (KR) 2023-05-10 EP disclosed
US-11434217-B2 Method for synthesis of lobaric acid and analog thereof KOREA INSTITUTE OF OCEAN SCIENCE AND TECHNOLOGY (KR) 2022-09-06 US disclosed
US-20210246112-A1 METHOD FOR SYNTHESIS OF LOBARIC ACID AND ANALOG THEREOF KOREA INSTITUTE OF OCEAN SCIENCE AND TECHNOLOGY (KR) 2021-08-12 US disclosed
EP-3733656-A1 METHOD FOR SYNTHESIS OF LOBARIC ACID AND ANALOG THEREOF Korea Institute of Ocean Science and Technology (KR) 2020-11-04 EP disclosed
CN-111819170-A Method for synthesizing pneumocandic acid and analogues thereof 韩国海洋研究院 2020-10-23 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210246112-A1 METHOD FOR SYNTHESIS OF LOBARIC ACID AND ANALOG THEREOF PPP6C, PPP4C, PPP3CB PTPN1 129/4885TDP1 2720/4885L3MBTL1 1721/4885
US-11434217-B2 Method for synthesis of lobaric acid and analog thereof PPP6C, PPP4C, PPP3CB PTPN1 129/4885TDP1 2720/4885L3MBTL1 1721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.